Anthropic’s rapid revenue expansion to a $65 billion annualized run rate, combined with its confidential June S-1 filing and Nasdaq listing targeted for mid-October 2026, drives trader consensus toward the $1.75–2.25 trillion valuation brackets. Secondary-market trading has already lifted implied values above the $965 billion May Series H round, while reports of potential $100 billion proceeds and anchor interest from Nvidia reinforce expectations of a substantial public-market premium. Competitive gains with Claude models, enterprise adoption, and major cloud partnerships support the pricing, though sustained compute costs and AI safety scrutiny could temper the final outcome ahead of the November midterms.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert$1.75–$2.00T 49%
$2.00–$2.25T 25.5%
$1.50–$1.75T 17.9%
$2.25–$2.50T 7.2%
$57,697 Vol.
$57,697 Vol.
31. Dez. 2027
<$1.25T
1%
$1.25–$1.50T
3%
$1.50–$1.75T
18%
$1.75–$2.00T
49%
$2.00–$2.25T
26%
$2.25–$2.50T
7%
$2.50T+
2%
No IPO by December 31, 2027
1%
$1.75–$2.00T 49%
$2.00–$2.25T 25.5%
$1.50–$1.75T 17.9%
$2.25–$2.50T 7.2%
$57,697 Vol.
$57,697 Vol.
31. Dez. 2027
<$1.25T
$2,606 Vol.
1%
$1.25–$1.50T
$3,317 Vol.
3%
$1.50–$1.75T
$9,866 Vol.
18%
$1.75–$2.00T
$20,660 Vol.
49%
$2.00–$2.25T
$11,526 Vol.
26%
$2.25–$2.50T
$3,420 Vol.
7%
$2.50T+
$3,250 Vol.
2%
No IPO by December 31, 2027
$3,054 Vol.
1%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion to a $65 billion annualized run rate, combined with its confidential June S-1 filing and Nasdaq listing targeted for mid-October 2026, drives trader consensus toward the $1.75–2.25 trillion valuation brackets. Secondary-market trading has already lifted implied values above the $965 billion May Series H round, while reports of potential $100 billion proceeds and anchor interest from Nvidia reinforce expectations of a substantial public-market premium. Competitive gains with Claude models, enterprise adoption, and major cloud partnerships support the pricing, though sustained compute costs and AI safety scrutiny could temper the final outcome ahead of the November midterms.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Markt eröffnet: Aug 19, 2026, 9:45 AM ET
Volumen
$57,697Enddatum
1. Jan. 2028Markt eröffnet
Aug 19, 2026, 9:45 AM ETAbwickler
0x69c47De9D...This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion to a $65 billion annualized run rate, combined with its confidential June S-1 filing and Nasdaq listing targeted for mid-October 2026, drives trader consensus toward the $1.75–2.25 trillion valuation brackets. Secondary-market trading has already lifted implied values above the $965 billion May Series H round, while reports of potential $100 billion proceeds and anchor interest from Nvidia reinforce expectations of a substantial public-market premium. Competitive gains with Claude models, enterprise adoption, and major cloud partnerships support the pricing, though sustained compute costs and AI safety scrutiny could temper the final outcome ahead of the November midterms.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Volumen
$57,697Enddatum
1. Jan. 2028Markt eröffnet
Aug 19, 2026, 9:45 AM ETAbwickler
0x69c47De9D...Anthropic’s rapid revenue expansion to a $65 billion annualized run rate, combined with its confidential June S-1 filing and Nasdaq listing targeted for mid-October 2026, drives trader consensus toward the $1.75–2.25 trillion valuation brackets. Secondary-market trading has already lifted implied values above the $965 billion May Series H round, while reports of potential $100 billion proceeds and anchor interest from Nvidia reinforce expectations of a substantial public-market premium. Competitive gains with Claude models, enterprise adoption, and major cloud partnerships support the pricing, though sustained compute costs and AI safety scrutiny could temper the final outcome ahead of the November midterms.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertVerwandte
Will Anthropic's market cap be between $2.25T and $2.5T at market close on IPO day?
26%
Wird die Marktkapitalisierung von Anthropic am Handelsschluss am Tag des Börsengangs bis zum 31. Dezember 2027 600 Mrd. $ oder mehr betragen?
96%
Ja
Will Anthropic’s market cap be 1.8T or greater at market close on IPO day by December 31 2027?
79%
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen